SYFOVRE Apellis Australia Pty Ltd
Product name
SYFOVRE
Sponsor
Accepted date
Mar-2023
Active ingredients
pegcetacoplan
Proposed indication
For the treatment of adults with geographic atrophy.
Application type
C (new indication)
Publication date
Mar-2023